January 29, 2019
Modus Therapeutics strengthens Board with two key appointments
Media
January 29, 2019
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
January 25, 2019
Nordic Nanovector – Private placement successfully completed
January 24, 2019
Nordic Nanovector ASA (OSE: NANO) nomination committee proposes new Chairman
January 24, 2019
Oncopeptides has completed a directed share issue of approximately SEK 546 million
January 17, 2019
Targovax granted European Patent for mutant-RAS neoantigen platform lead products
January 11, 2019
Actavis infringes Orexo’s long term Zubsolv® US patent ´330
January 07, 2019
Modus Therapeutics completes enrollment of randomized, placebo-controlled Phase II clinical trial evaluating sevuparin for management of Acute Vaso-Occlusive Crisis in SCD patients
January 07, 2019
Aprea Therapeutics Announces Presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco
January 07, 2019
Positive results from human PK study assessing Orexo’s new intranasal naloxone formulations for opioid overdose reversal
